PharmaEssentia Corporation (TPE:6446)
1,190.00
-50.00 (-4.03%)
Oct 30, 2026, 1:30 PM CST
PharmaEssentia Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, PharmaEssentia stock has a consensus rating of "Buy" and an average price target of $1,437. The average 1-year stock price forecast is 20.78% higher than the current stock price, while the lowest is $500.33 (-57.96%) and the highest is $2,143 (+80.08%).
Price Target: $1,437 (+20.78%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PharmaEssentia stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
27.07B
from 15.63B
Increased by 73.15%
Revenue Next Year
41.50B
from 27.07B
Increased by 53.31%
EPS This Year
26.88
from 12.25
Increased by 119.41%
EPS Next Year
43.95
from 26.88
Increased by 63.50%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.